These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 16150917

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
    Martin NM, Small CJ, Sajedi A, Patterson M, Ghatei MA, Bloom SR.
    Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Glucagon-like peptide-1-(7-36) amide and peptide YY mediate intraduodenal fat-induced inhibition of acid secretion in dogs.
    Fung LC, Chisholm C, Greenberg GR.
    Endocrinology; 1998 Jan; 139(1):189-94. PubMed ID: 9421414
    [Abstract] [Full Text] [Related]

  • 28. Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats.
    Chelikani PK, Haver AC, Reidelberger RD.
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R39-46. PubMed ID: 17428898
    [Abstract] [Full Text] [Related]

  • 29. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
    Navarro M, Rodriquez de Fonseca F, Alvarez E, Chowen JA, Zueco JA, Gomez R, Eng J, Blázquez E.
    J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of food intake in obese subjects by peptide YY3-36.
    Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR.
    N Engl J Med; 2003 Sep 04; 349(10):941-8. PubMed ID: 12954742
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
    Roth JD, Coffey T, Jodka CM, Maier H, Athanacio JR, Mack CM, Weyer C, Parkes DG.
    Endocrinology; 2007 Dec 04; 148(12):6054-61. PubMed ID: 17761760
    [Abstract] [Full Text] [Related]

  • 33. Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects.
    Steinert RE, Poller B, Castelli MC, Drewe J, Beglinger C.
    Am J Clin Nutr; 2010 Oct 04; 92(4):810-7. PubMed ID: 20720259
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man.
    Wettergren A, Maina P, Boesby S, Holst JJ.
    Scand J Gastroenterol; 1997 Jun 04; 32(6):552-5. PubMed ID: 9200286
    [Abstract] [Full Text] [Related]

  • 37. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
    Näslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ, Rössner S, Hellström PM.
    Int J Obes Relat Metab Disord; 1999 Mar 04; 23(3):304-11. PubMed ID: 10193877
    [Abstract] [Full Text] [Related]

  • 38. Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males.
    Sloth B, Davidsen L, Holst JJ, Flint A, Astrup A.
    Am J Physiol Endocrinol Metab; 2007 Aug 04; 293(2):E604-9. PubMed ID: 17566112
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus).
    Blanco AM, Bertucci JI, Valenciano AI, Delgado MJ, Unniappan S.
    Horm Behav; 2017 Jul 04; 93():62-71. PubMed ID: 28506816
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.